Sequent Scientific has entered into a definitive agreement with promoter Dr.Huseyin Aydin for the acquisition of 40% stake from him in Provet for $17.1 million. Provet is amongst the top 3 and the largest local company in the veterinary medicines market in Turkey. - Positive.
Feedback
SEQUENT 
Reputation: 263 • Sep 23, 2020 2:21 PM
Vote
Comment
Share
NSE:SEQUENT price when posted: 144.35